HOMEVULNERABILITIESCVE-2020-16198
MEDIUM

CVE-2020-16198

CWE-693Published: September 18, 2020· Updated: Jun 17, 2026

6.3
CVSS v3.1

Official Description

When an attacker claims to have a given identity,

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior,

does not prove or insufficiently proves the claim is correct.

NVD Source

Technical Analysis

CVE-2020-16198 requires adjacent network access, limiting remote exploitation but still posing risk in shared or local network environments.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorAdjacent
Attack ComplexityLow
Privileges Req.None
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityLow
IntegrityLow
AvailabilityLow
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

Affected Vendors & Products

philips1 product(s)
clinical collaboration platform
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (3)

Quick Facts

CVE IDCVE-2020-16198
CVSS Score6.3 / 10
SeverityMEDIUM
WeaknessCWE-693
CISA KEVNo
Affected1 vendor(s)
PublishedSep 18, 2020

Related CVEs (CWE-693)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2020-16198 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.